You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《全日總結》恆指升109點 醫藥股彈高 小鵬回吐逾6%
港股今日先跌後回升,恆指今早低開17點後掉頭向上,曾倒升142點一度高見19,449點,全日升109點或0.6%,收19,415點;國指升22點或0.3%,收6,613點;恆生科技指數升20點或0.5%,收4,074點。大市全日成交總額760.46億元,滬、深港通南下交易淨流入3億及17.25億元人民幣。 商湯(00020.HK)開市前錄得多宗大額成交,涉及逾10億股,每股作價1.82元至1.95元,共計超過20億元。該股跌8.7%報1.99元,成交額逾34億元。其他科技股方面,阿里(09988.HK)升0.5%報84元,騰訊(00700.HK)升0.4%報339.2元,美團(03690.HK)、小米(01810.HK)、百度(09888.HK)及網易(09999.HK)升0.9%至1.6%,其中網易見逾一年高。京東(09618.HK)升2.8%,快手(01024.HK)升0.3%。東方甄選(01797.HK)升15.4%。 電動車股普遍回吐,小鵬(09868.HK)6月交付按月增15%,今日股價回吐6.5%,零跑(09863.HK)及蔚來(09866.HK)跌4.1%及4.9%,理想(02015.HK)跌近2%,比亞迪(01211.HK)升1.4%報264.8元。手機部件股丘鈦(01478.HK)升5.8%,舜宇(02382.HK)及瑞聲(02018.HK)升1.5%,比亞迪電子(00285.HK)升2.2%。 國家醫保局就《談判藥品續約規則》及《非獨家藥品競價規則》公開微求意見,醫藥股急彈,翰森製藥(03692.HK)升6.6%,為升幅最大藍籌。石藥(01093.HK)、中生製藥(01177.HK)及藥明生物(02269.HK)升2.7%至3.5%,信達生物(01801.HK)、百濟神州(06160.HK)及康方生物(09926.HK)炒高9.2%至10.9%,綠葉製藥(02186.HK)亦升4.9%。 據報英國將傳召匯控(00005.HK)等銀行要求提高存息,匯控升0.5%報62.25元,盤中曾高見62.45元,為2019年8月以來新高。 中遠海控(01919.HK)預告半年純利跌74.5%,券商指業績勝預期,全日股價升4.1%。同業東方海外(00316.HK)升3.9%。JS環球生活(01691.HK)擬就分拆SharkNinja赴美上市向股東分配股份,股價升3.3%。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account